Humana is a leading health insurance company that provides a wide range of health and wellness solutions to individuals, families, and employers. The organization offers Medicare Advantage plans, Medicaid services, and individual health insurance policies, focusing on enhancing the health and well-being of its members. Additionally, Humana invests in technology and innovative care management services, aiming to improve healthcare delivery and patient outcomes. The company is dedicated to integrating medical and wellness services to create a comprehensive approach to health management for its customers. Read More
Stay tuned for the market movements in the S&P500 index on Wednesday. Check out the gap up and gap down stocks in the S&P500 index during today's session.
Health insurance company Humana (NYSE:HUM) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 11.4% year on year to $32.65 billion. The company expects the full year’s revenue to be around $128 billion, close to analysts’ estimates. Its GAAP profit of $1.62 per share was 43.4% below analysts’ consensus estimates.
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.
Humana beat Q3 2025 earnings estimates with adjusted EPS of $3.24. Despite the profit beat, shares fell due to a significant gap between GAAP and non-GAAP results and revised full-year guidance.
Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended September 30, 2025 (3Q25) versus the quarter ended September 30, 2024 (3Q24) and for the nine months ended September 30, 2025 (YTD 2025) versus the nine months ended September 30, 2024 (YTD 2024) as noted in the tables below.
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.
Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on January 30, 2026 to stockholders of record as of the close of business on December 26, 2025.
New York, NY – October 23, 2025 – The healthcare sector of the S&P 500 experienced a significant downturn today, conspicuously underperforming the broader market as a relentless surge in medical costs continues to erode the profitability of health insurers. This slump was epitomized by a dramatic sell-off in Molina Healthcare
Following World Mental Health Day, the Humana Foundation – the philanthropic arm of Humana Inc. for the past 44 years – along with Jewish Heritage Fund and the University of Louisville’s Christina Lee Brown Envirome Institute, announced the grand opening of the new “Health and Well-being Center” at Junior Achievement (JA) Finance Park of Kentucky. The milestone was marked with a ribbon-cutting ceremony at the Park.
